Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment

Glioblastoma, the most common and aggressive primary brain tumor, remains a significant challenge in oncology due to its immunosuppressive tumor microenvironment (TME). This review summarizes the complex interplay of immune cells and cytokines within the TME, which contribute to immune evasion and t...

Full description

Saved in:
Bibliographic Details
Main Authors: Dongxin Jiang, Yunqian Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1590781/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849321461845590016
author Dongxin Jiang
Yunqian Li
author_facet Dongxin Jiang
Yunqian Li
author_sort Dongxin Jiang
collection DOAJ
description Glioblastoma, the most common and aggressive primary brain tumor, remains a significant challenge in oncology due to its immunosuppressive tumor microenvironment (TME). This review summarizes the complex interplay of immune cells and cytokines within the TME, which contribute to immune evasion and tumor progression. We further emphasize the synergistic crosstalk among these components and how it shapes therapeutic vulnerability. Besides, we highlight recent advancements in immunotherapy, including immune checkpoint inhibitors, CAR-T cell therapy, NK cell therapy, oncolytic viruses, and vaccine-based strategies. Despite promising preclinical and clinical results, overcoming the immunosuppressive TME remains a critical hurdle. This review underscores the potential of targeting the TME to enhance therapeutic outcomes in glioblastoma.
format Article
id doaj-art-0cdea6defc4c4d0fa904ad2570cb3bce
institution Kabale University
issn 1664-3224
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-0cdea6defc4c4d0fa904ad2570cb3bce2025-08-20T03:49:45ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-05-011610.3389/fimmu.2025.15907811590781Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatmentDongxin JiangYunqian LiGlioblastoma, the most common and aggressive primary brain tumor, remains a significant challenge in oncology due to its immunosuppressive tumor microenvironment (TME). This review summarizes the complex interplay of immune cells and cytokines within the TME, which contribute to immune evasion and tumor progression. We further emphasize the synergistic crosstalk among these components and how it shapes therapeutic vulnerability. Besides, we highlight recent advancements in immunotherapy, including immune checkpoint inhibitors, CAR-T cell therapy, NK cell therapy, oncolytic viruses, and vaccine-based strategies. Despite promising preclinical and clinical results, overcoming the immunosuppressive TME remains a critical hurdle. This review underscores the potential of targeting the TME to enhance therapeutic outcomes in glioblastoma.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1590781/fullglioblastomaimmune microenvironmentcytokinesimmunotherapyimmune checkpoint inhibitortumor vaccine
spellingShingle Dongxin Jiang
Yunqian Li
Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
Frontiers in Immunology
glioblastoma
immune microenvironment
cytokines
immunotherapy
immune checkpoint inhibitor
tumor vaccine
title Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
title_full Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
title_fullStr Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
title_full_unstemmed Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
title_short Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
title_sort unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
topic glioblastoma
immune microenvironment
cytokines
immunotherapy
immune checkpoint inhibitor
tumor vaccine
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1590781/full
work_keys_str_mv AT dongxinjiang unravelingtheimmunosuppressivemicroenvironmentofglioblastomaandadvancementsintreatment
AT yunqianli unravelingtheimmunosuppressivemicroenvironmentofglioblastomaandadvancementsintreatment